Diabetes medicine reduces Parkinson's risk

September 25, 2017, University of Bergen
Charalampos Tzoulis (right) and his colleagues, Kristoffer Haugarvoll (left) and Brage Brakedal, hope they are one step closer to a cure for Parkinson´s disease. Credit: Kim E. Andreassen

A Norwegian study shows that the taking of diabetes medicine reduces the risk of getting Parkinson's disease.

Researchers at the Department of Clinical Medicine at the University of Bergen (UiB) have discovered that against diabetes reduces the risk of getting Parkinson's disease by 35 per cent.

"We have made an important discovery, which takes us a step further towards solving the Parkinson's riddle," says researcher Charalampos Tzoulis. He has lead the study together with researcher Kristoffer Haugarvoll at the same department.

One step further

Tzoulis says that the researchers have to do follow-up studies on the diabetes to fully understand why it protects against Parkinson's disease.

"If we understand the mechanisms behind the protection, then we have a chance to develop a new treatment," Tzoulis says.

Influence the cell's powerhouse

The researchers believe that the diabetes medicines, containing so-called glitazones, are influencing the cells to produce more mitochondria. Mitochondria are the powerhouse of the cells, transforming nutrients that the cells need to work.

Tzoulis' research group has previously shown that the production of mitochondria decreases during Parkinson's.

100 million prescriptions

To see the connection between and Parkinson's, the researchers analysed and compared data from the Norwegian Prescription Data Base. The database has stored information on all use of prescription the last 10 years and contains data on more than 100 million .

Explore further: Getting closer to treatment for Parkinson's

Related Stories

Getting closer to treatment for Parkinson's

January 23, 2017
More than 10 million people worldwide have Parkinson's disease. The cause of Parkinson's disease is unknown and thus no effective treatments exist. A study from the University of Bergen (UiB) suggests that the secret of the ...

Why a diabetes drug could help in Parkinson's disease

August 29, 2017
A diabetes drug might help in certain types of Parkinson's disease, reports a team of German brain researchers headed by Dr. Julia Fitzgerald at the Hertie Institute for Clinical Brain Research, the University of Tübingen ...

Diabetes drug may protect against Parkinson's disease

July 21, 2015
A type of drug used to treat diabetes may reduce the risk of developing Parkinson's disease, according to a new study published in PLOS Medicine.

Statins may not be used for protection against Parkinson's disease

June 14, 2017
Use of statins may speed up the onset of Parkinson's disease symptoms in people who are susceptible to the disease, according to Penn State College of Medicine researchers.

Mitochondrial lipids as potential targets in early onset Parkinson's disease

February 10, 2017
A team of researchers led by Patrik Verstreken (VIB–KU Leuven) have identified an underlying mechanism in early onset Parkinson's. Using flies, mice and patient cells, the team focused on cardiolipin, a fat unique to cells' ...

Get a clue: Biochemist studies fruit fly to understand Parkinson's disease, muscle wasting

June 22, 2016
The fruit fly may help us be less clueless about human muscle development and Parkinson's disease.

Recommended for you

New transgenic model of Parkinson's illuminates disease biology

October 11, 2018
Parkinson's disease (PD) is a neurodegenerative disorder that presents clinically with abnormal movement and tremors at rest. In the brain, PD is marked by the accumulation of the protein, α-synuclein (αS), into clumps ...

Early Parkinson's patients waiting too long to seek medical evaluation

September 27, 2018
The time between diagnosis and the institution of symptomatic treatment is critical in the effort to find a cure for Parkinson's Disease (PD). A paper published in Nature Partner Journal: Parkinson's Disease notes too many ...

Molecule capable of halting and reverting neurodegeneration caused by Parkinson's disease identified

September 25, 2018
The small SynuClean-D molecule interrupts the formation of the alpha-synuclein amyloid fibres responsible for the onset of Parkinson's disease, and reverts the neurodegeneration caused by the disease. The study, headed by ...

Genomic dark matter activity connects Parkinson's and psychiatric diseases

September 20, 2018
Dopamine neurons are located in the midbrain, but their tendril-like axons can branch far into the higher cortical areas, influencing how we move and how we feel. New genetic evidence has revealed that these specialized cells ...

Gene therapy shown to remove core component of Parkinson's disease

September 14, 2018
An international team led by Rush researcher Jeffrey Kordower, Ph.D., has moved a step closer to developing a treatment to clear brain cells of a protein that is an integral cause of Parkinson's disease. The team published ...

ADHD may increase risk of Parkinson's disease and similar disorders

September 12, 2018
While about 11 percent of children (4-17 years old) nationwide have been diagnosed with attention-deficit hyperactivity disorder (ADHD), the long-term health effects of having ADHD and of common ADHD medications remains understudied. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.